title: Therapy for Tuberculous Meningitis.
authors.affiliation: Radboud University Medical Center, Nijmegen, the Netherlands Martin.Boeree@radboudumc.nl.
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Boeree
authors.affiliation: University of St. Andrews, St. Andrews, United Kingdom.
authors.forename: Stephen H
authors.initials: SH
authors.lastname: Gillespie
authors.affiliation: University of Munich, Munich, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Hoelscher
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000995:Antitubercular Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D064704:Levofloxacin / Q000008:administration & dosage*; D008297:Male; D012293:Rifampin / Q000008:administration & dosage*; D014390:Tuberculosis, Meningeal / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D064704:Levofloxacin; D012293:Rifampin